Chlorpheniramine



Indications and Reactions:

Role Indications Reactions
Primary
Sinusitis 28.6%
Lower Respiratory Tract Infection 14.3%
Pain 14.3%
Pruritus 14.3%
Sleep Disorder 14.3%
Urticaria 14.3%
Sedation 20.0%
Drug Abuse 13.3%
Somnolence 13.3%
Atrial Fibrillation 6.7%
Dyspnoea 6.7%
Lip Swelling 6.7%
Memory Impairment 6.7%
Nervous System Disorder 6.7%
Rib Fracture 6.7%
Unresponsive To Stimuli 6.7%
Venoocclusive Liver Disease 6.7%
Secondary
Product Used For Unknown Indication 61.4%
Drug Use For Unknown Indication 13.9%
Breast Cancer 5.1%
Evidence Based Treatment 3.8%
Itchy Rash 1.9%
Oropharyngeal Pain 1.9%
Rash Pruritic 1.9%
Ankle Sprain 1.3%
Bronchitis 1.3%
Dermatitis Infected 1.3%
Ligament Sprain 1.3%
Swelling 1.3%
Accidental Exposure 0.6%
Blood Cholesterol Increased 0.6%
Drug Exposure During Pregnancy 0.6%
Itching 0.6%
Pruritus 0.6%
Type Iia Hyperlipidaemia 0.6%
Toxicity To Various Agents 20.4%
Death 10.2%
Drug Abuse 6.1%
Intentional Drug Misuse 6.1%
Tachycardia 6.1%
Unresponsive To Stimuli 6.1%
Wrong Drug Administered 6.1%
Drug Toxicity 4.1%
Hypotension 4.1%
Metastases To Bone 4.1%
Pyrexia 4.1%
Respiratory Arrest 4.1%
Skin Exfoliation 4.1%
Cleft Palate 2.0%
Completed Suicide 2.0%
Drug Hypersensitivity 2.0%
Dyspnoea 2.0%
Intentional Overdose 2.0%
No Adverse Event 2.0%
Overdose 2.0%
Concomitant
Product Used For Unknown Indication 27.5%
Chronic Lymphocytic Leukaemia 19.0%
Premedication 6.7%
Prophylaxis 6.7%
Pain 6.3%
Nausea 3.3%
Antifungal Prophylaxis 2.9%
Diarrhoea 2.9%
Diffuse Large B-cell Lymphoma 2.8%
Hypertension 2.8%
Colorectal Cancer Metastatic 2.6%
Pyrexia 2.5%
Hypersensitivity 2.3%
Graft Versus Host Disease 2.2%
Sarcoma 2.0%
Acute Myeloid Leukaemia 1.8%
Stomatitis 1.6%
Breast Cancer 1.4%
Gastric Cancer 1.4%
Urticaria 1.4%
Febrile Neutropenia 14.0%
Renal Failure Acute 8.6%
Tachycardia 8.6%
Neutropenic Sepsis 6.5%
Mobility Decreased 5.4%
Thrombocytopenia 5.4%
Congenital Anomaly 4.3%
Drug Ineffective 4.3%
Lung Infection 4.3%
Sepsis 4.3%
Suicidal Ideation 4.3%
Vomiting 4.3%
Hyponatraemia 3.2%
Infection 3.2%
Injection Site Reaction 3.2%
Pneumonia 3.2%
Psoriasis 3.2%
Pyrexia 3.2%
Rash 3.2%
Rash Maculo-papular 3.2%
Interacting
Epilepsy 83.3%
Seasonal Allergy 16.7%
Toxicity To Various Agents 100.0%